CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 625 of 658 entries

View as:

Pacemaker and Defibrillator Lead Extraction Registry

Phase: N/A Priority: Normal

NCT ID: NCT03847025 Org: User:

Start: 09/30/13 End: 09/30/27 Due: 09/30/28

Efalizumab for Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal

NCT ID: NCT00226057 Org: User:

Start: 06/30/05 End: 05/31/06 Due: 05/31/07

Immediate Postplacental IUD Insertion

Phase: N/A Priority: Normal

NCT ID: NCT02169869 Org: User:

Start: 09/30/14 End: 06/30/17 Due: 06/30/18

Below Knee DVT Study

Phase: N/A Priority: Normal

NCT ID: NCT03805672 Org: User:

Start: 09/30/14 End: 07/31/15 Due: 07/31/16

Real-time Assessment of Frameless Intrafraction Motion

Phase: N/A Priority: Normal

NCT ID: NCT01202539 Org: User:

Start: 09/30/10 End: 09/30/11 Due: 09/30/12

Preterm Infant Inhaled Albuterol Dosing

Phase: N/A Priority: Normal

NCT ID: NCT02447250 Org: User:

Start: 10/24/13 End: 12/30/14 Due: 12/30/15

Assessment of a Decision Support Tool in Participants With Type 1 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT04428645 Org: User:

Start: 07/21/20 End: 11/15/21 Due: 11/15/22

A Clinical Trial of Infliximab for Uveitis

Phase: N/A Priority: Normal

NCT ID: NCT00273390 Org: User:

Start: 08/31/01 End: 12/31/06 Due: 12/31/07

Postural Instability in Progressive Supranuclear Palsy

Phase: N/A Priority: Normal

NCT ID: NCT01563276 Org: User:

Start: 12/31/11 End: 05/10/13 Due: 05/10/14

Autism Access Link for Early Referral and Treatment

Phase: N/A Priority: Normal

NCT ID: NCT04861740 Org: User:

Start: 09/01/20 End: 01/04/24 Due: 01/04/25

Focus Groups in Ethnically and Racially Diverse Families

Phase: N/A Priority: Normal

NCT ID: NCT05930886 Org: User:

Start: 04/15/23 End: 10/04/25 Due: 10/04/26

Health Protection & Promotion for Oregon Correctional Officers

Phase: N/A Priority: Normal

NCT ID: NCT02098603 Org: User:

Start: 01/31/13 End: 09/30/14 Due: 09/30/15

Expectation and Response to Levodopa and Acupuncture in Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00692328 Org: User:

Start: 08/31/05 End: 02/28/07 Due: 02/28/08

Collagen Cross-linking in Keratoconus

Phase: N/A Priority: Normal

NCT ID: NCT03760432 Org: User:

Start: 06/20/18 End: 12/31/25 Due: 12/31/26

Lipoic Acid as a Treatment for Acute Optic Neuritis

Phase: N/A Priority: Normal

NCT ID: NCT01294176 Org: User:

Start: 01/31/11 End: 11/30/16 Due: 11/30/17

Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy

Phase: N/A Priority: Normal

NCT ID: NCT00982787 Org: User:

Start: 09/30/09 End: 01/31/11 Due: 01/31/12

rTMS for Craving in Methamphetamine Use Disorder

Phase: N/A Priority: Normal

NCT ID: NCT03470480 Org: User:

Start: 02/07/18 End: 09/01/25 Due: 09/01/26

Autism ALERT Expansion

Phase: N/A Priority: Normal

NCT ID: NCT06246890 Org: User:

Start: 01/30/24 End: 01/01/28 Due: 01/01/29

Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure

Phase: N/A Priority: Normal

NCT ID: NCT00575419 Org: User:

Start: 11/30/07 End: 09/15/14 Due: 09/15/15

Fludrocortisone for Sudden Hearing Loss

Phase: N/A Priority: Normal

NCT ID: NCT01186185 Org: User:

Start: 08/31/12 End: 03/31/16 Due: 03/31/17

Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device

Phase: N/A Priority: Normal

NCT ID: NCT01311128 Org: User:

Start: 02/16/11 End: 12/30/14 Due: 12/30/15

Low-dose Propofol for Pediatric Migraine

Phase: N/A Priority: Normal

NCT ID: NCT01604785 Org: User:

Start: 11/30/12 End: 08/31/16 Due: 08/31/17

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT01356420 Org: User:

Start: 01/31/11 End: 12/31/15 Due: 12/31/16

A Study of Continuous Oral Contraceptives and Doxycycline

Phase: N/A Priority: Normal

NCT ID: NCT00480532 Org: User:

Start: 05/31/07 End: 05/31/11 Due: 05/31/12

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

Phase: N/A Priority: Normal

NCT ID: NCT02968212 Org: User:

Start: 04/11/17 End: 05/31/25 Due: 05/31/26

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Pacemaker and Defibrillator Lead Extraction Registry	NCT03847025	Oregon Health and Science University	user2@example.com	None	2013-09-30	2027-09-30	2028-09-30	-	-	2025-07-14
Efalizumab for Moderate to Severe Atopic Dermatitis	NCT00226057	Oregon Health and Science University	user2@example.com	None	2005-06-30	2006-05-31	2007-05-31	-	-	2025-07-14
Immediate Postplacental IUD Insertion	NCT02169869	Oregon Health and Science University	user2@example.com	None	2014-09-30	2017-06-30	2018-06-30	-	-	2025-07-14
Below Knee DVT Study	NCT03805672	Oregon Health and Science University	user2@example.com	None	2014-09-30	2015-07-31	2016-07-31	-	-	2025-07-14
Real-time Assessment of Frameless Intrafraction Motion	NCT01202539	Oregon Health and Science University	user2@example.com	None	2010-09-30	2011-09-30	2012-09-30	-	-	2025-07-14
Preterm Infant Inhaled Albuterol Dosing	NCT02447250	Oregon Health and Science University	user2@example.com	None	2013-10-24	2014-12-30	2015-12-30	-	-	2025-07-14
Assessment of a Decision Support Tool in Participants With Type 1 Diabetes	NCT04428645	Oregon Health and Science University	user2@example.com	None	2020-07-21	2021-11-15	2022-11-15	-	-	2025-07-14
A Clinical Trial of Infliximab for Uveitis	NCT00273390	Oregon Health and Science University	user2@example.com	None	2001-08-31	2006-12-31	2007-12-31	-	-	2025-07-14
Postural Instability in Progressive Supranuclear Palsy	NCT01563276	Oregon Health and Science University	user2@example.com	None	2011-12-31	2013-05-10	2014-05-10	-	-	2025-07-14
Autism Access Link for Early Referral and Treatment	NCT04861740	Oregon Health and Science University	user2@example.com	None	2020-09-01	2024-01-04	2025-01-04	-	-	2025-07-14
Focus Groups in Ethnically and Racially Diverse Families	NCT05930886	Oregon Health and Science University	user2@example.com	None	2023-04-15	2025-10-04	2026-10-04	-	-	2025-07-14
Health Protection & Promotion for Oregon Correctional Officers	NCT02098603	Oregon Health and Science University	user2@example.com	None	2013-01-31	2014-09-30	2015-09-30	-	-	2025-07-14
Expectation and Response to Levodopa and Acupuncture in Parkinson's Disease	NCT00692328	Oregon Health and Science University	user2@example.com	None	2005-08-31	2007-02-28	2008-02-28	-	-	2025-07-14
Collagen Cross-linking in Keratoconus	NCT03760432	Oregon Health and Science University	user2@example.com	None	2018-06-20	2025-12-31	2026-12-31	-	-	2025-07-14
Lipoic Acid as a Treatment for Acute Optic Neuritis	NCT01294176	Oregon Health and Science University	user2@example.com	None	2011-01-31	2016-11-30	2017-11-30	-	-	2025-07-14
Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy	NCT00982787	Oregon Health and Science University	user2@example.com	None	2009-09-30	2011-01-31	2012-01-31	-	-	2025-07-14
rTMS for Craving in Methamphetamine Use Disorder	NCT03470480	Oregon Health and Science University	user2@example.com	None	2018-02-07	2025-09-01	2026-09-01	-	-	2025-07-14
Autism ALERT Expansion	NCT06246890	Oregon Health and Science University	user2@example.com	None	2024-01-30	2028-01-01	2029-01-01	-	-	2025-07-14
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure	NCT00575419	Oregon Health and Science University	user2@example.com	None	2007-11-30	2014-09-15	2015-09-15	-	-	2025-07-14
Fludrocortisone for Sudden Hearing Loss	NCT01186185	Oregon Health and Science University	user2@example.com	None	2012-08-31	2016-03-31	2017-03-31	-	-	2025-07-14
Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device	NCT01311128	Oregon Health and Science University	user2@example.com	None	2011-02-16	2014-12-30	2015-12-30	-	-	2025-07-14
Low-dose Propofol for Pediatric Migraine	NCT01604785	Oregon Health and Science University	user2@example.com	None	2012-11-30	2016-08-31	2017-08-31	-	-	2025-07-14
Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome	NCT01356420	Oregon Health and Science University	user2@example.com	None	2011-01-31	2015-12-31	2016-12-31	-	-	2025-07-14
A Study of Continuous Oral Contraceptives and Doxycycline	NCT00480532	Oregon Health and Science University	user2@example.com	None	2007-05-31	2011-05-31	2012-05-31	-	-	2025-07-14
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)	NCT02968212	Oregon Health and Science University	user2@example.com	None	2017-04-11	2025-05-31	2026-05-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance